Stock SEM SELECT MEDICAL HOLDINGS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Select Medical Holdings Corporation

Equities

SEM

US81619Q1058

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
27.41 USD +0.07% Intraday chart for Select Medical Holdings Corporation +1.29% +16.64%
Apr. 25 Transcript : Select Medical Holdings Corporation - Shareholder/Analyst Call
Apr. 02 Select Medical, UF Health Jacksonville Joint Venture to Open 48-Bed Rehabilitation Hospital MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,135 3,728 3,944 3,153 3,013 3,518 - -
Enterprise Value (EV) 1 6,244 6,552 7,486 6,935 6,587 6,925 6,691 6,402
P/E ratio 21.2 x 14.3 x 9.87 x 20.2 x 12.3 x 13.4 x 12.8 x 10.8 x
Yield - - 1.7% 2.01% 2.13% 1.82% 1.82% 1.82%
Capitalization / Revenue 0.57 x 0.67 x 0.64 x 0.5 x 0.45 x 0.5 x 0.48 x 0.46 x
EV / Revenue 1.14 x 1.18 x 1.21 x 1.09 x 0.99 x 0.99 x 0.92 x 0.84 x
EV / EBITDA 8.78 x 8.18 x 7.9 x 10.7 x 8.16 x 8.1 x 7.34 x 6.36 x
EV / FCF 21,677,727 x 7,432,230 x 33,920,109 x 73,419,152 x - - - -
FCF Yield 0% 0% 0% 0% - - - -
Price to Book 3.9 x 3.52 x 3.55 x 2.81 x 2.34 x 2.3 x 2.03 x 1.77 x
Nbr of stocks (in thousands) 134,326 134,763 134,145 126,984 128,214 128,358 - -
Reference price 2 23.34 27.66 29.40 24.83 23.50 27.41 27.41 27.41
Announcement Date 2/20/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,454 5,532 6,205 6,334 6,664 6,968 7,287 7,622
EBITDA 1 710.9 800.6 947.4 646.9 807.4 855.2 911.9 1,007
EBIT 1 471.9 567.7 713.8 403.3 554.9 614.9 682.3 741.8
Operating Margin 8.65% 10.26% 11.5% 6.37% 8.33% 8.83% 9.36% 9.73%
Earnings before Tax (EBT) 1 264.7 456.5 629.7 260.6 382.4 389.1 439.9 540.2
Net income 1 148.4 259 388.8 159 243.5 361.4 407.4 335.5
Net margin 2.72% 4.68% 6.27% 2.51% 3.65% 5.19% 5.59% 4.4%
EPS 2 1.100 1.930 2.980 1.230 1.910 2.042 2.150 2.527
Free Cash Flow 288.1 881.6 220.7 94.45 - - - -
FCF margin 5.28% 15.94% 3.56% 1.49% - - - -
FCF Conversion (EBITDA) 40.52% 110.13% 23.3% 14.6% - - - -
FCF Conversion (Net income) 194.04% 340.41% 56.76% 59.41% - - - -
Dividend per Share 2 - - 0.5000 0.5000 0.5000 0.5000 0.5000 0.5000
Announcement Date 2/20/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1,534 1,560 1,600 1,585 1,568 1,581 1,665 1,675 1,666 1,659 1,738 1,752 1,742 1,736 1,822
EBITDA 1 208.6 138.4 163.8 181 153.1 148.9 214.1 219.5 193.8 180.1 222.5 233 206.1 193.6 237.5
EBIT 1 150.3 77.54 104 121 91.47 86.86 151.5 159.2 130 114.3 159.7 172.8 144.9 132.9 177.6
Operating Margin 9.79% 4.97% 6.5% 7.63% 5.83% 5.49% 9.1% 9.51% 7.8% 6.89% 9.19% 9.87% 8.32% 7.66% 9.74%
Earnings before Tax (EBT) 1 127.9 57.67 73.87 86.08 54.35 46.28 111.4 120.7 76.56 73.47 112.1 130.7 103.1 71.45 118.9
Net income 1 74.38 48.2 49.12 53.29 27.17 27.5 70.8 75.36 48.18 46.27 91.12 105.4 80.23 51.05 74.9
Net margin 4.85% 3.09% 3.07% 3.36% 1.73% 1.74% 4.25% 4.5% 2.89% 2.79% 5.24% 6.02% 4.61% 2.94% 4.11%
EPS 2 0.5700 0.3700 0.3700 0.4300 0.2100 0.2200 0.5600 0.6100 0.3800 0.3600 0.5703 0.6580 0.4941 0.3173 0.5492
Dividend per Share 2 0.1250 - - - - 0.1250 0.1250 0.1250 - 0.1250 0.1250 0.1250 0.1250 0.1250 0.1250
Announcement Date 11/4/21 2/24/22 5/5/22 8/4/22 11/3/22 2/23/23 5/4/23 8/3/23 11/2/23 2/22/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3,109 2,825 3,542 3,782 3,574 3,407 3,173 2,884
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 4.374 x 3.529 x 3.739 x 5.846 x 4.426 x 3.984 x 3.479 x 2.863 x
Free Cash Flow 288 882 221 94.5 - - - -
ROE (net income / shareholders' equity) 18.9% 28.3% 37.1% 14.2% 20.3% 17% 15.3% 15.7%
ROA (Net income/ Total Assets) 2.23% 3.45% 5.36% 2.12% 3.19% 3.29% 3.76% 4.14%
Assets 1 6,657 7,498 7,257 7,513 7,638 10,970 10,833 8,095
Book Value Per Share 2 5.980 7.860 8.290 8.820 10.00 11.90 13.50 15.50
Cash Flow per Share 2 3.420 7.920 3.080 2.290 4.730 4.640 4.900 5.280
Capex 1 157 146 181 190 229 231 214 219
Capex / Sales 2.88% 2.65% 2.91% 3.01% 3.44% 3.31% 2.94% 2.87%
Announcement Date 2/20/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Select Medical Holdings Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
27.41 USD
Average target price
35.8 USD
Spread / Average Target
+30.61%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
SELECT MEDICAL HOLDINGS CORPORATION Stock Select Medical Holdings Corporation
+16.64% 3.52B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. SEM Stock
  4. Financials Select Medical Holdings Corporation